Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Site-1 protease (S1P), also known as SKI-1 or PCSK8, is a serine protease that plays a central role in regulated intramembrane proteolysis. It is crucial for activating sterol regulatory element-binding proteins (SREBPs), which regulate cholesterol and fatty acid synthesis. S1P also activates ATF6 during ER stress and is involved in lysosome biogenesis. It is a potential drug target for lipid-lowering therapies, but its inhibition requires careful consideration due to its diverse roles and potential developmental consequences.
S1P cleaves specific substrates at non-basic residues after hydrophobic or small amino acids if Arg or Lys is at position P4. This cleavage activates key transcription factors such as SREBPs and ATF6, influencing lipid metabolism, ER stress response, and lysosome biogenesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Site-1 Protease (S1P).